CTRI/2023/06/054257Not yet recruitingUnknown
An intervention based Prospective study to assess the efficacy of CognitiveBotics software (an indigenously developed AI based software) in providing the integrated interventions in different domains - the social or emotional, language or communication, cognitive and movement or physical development of children diagnosed with Autism Spectrum Disorder. - NI
CognitiveBotics Technologies Private Limited0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Unknown
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Children diagnosed ASD using assessment scales such as
- •Childhood Autism Rating Scales (CARS)
- •2. Children with 2 to 18 years
- •3. Children with associated comorbidities will be included as long as the child is able to use the tool.
- •4. Ability to understand and respond to instructions given in English
- •5. Access to a device on which the software can be accessed using internet connection.
- •6. Parents who have consented for their child to use the software.
Exclusion Criteria
- •1. Children with intellectual disability with IQ score <50.
- •2. Parents who are not willing to consent to the study.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
APPRECIATERheumatoid arthritisJPRN-jRCTs031210665Kawahito Yutaka55
Recruiting
Phase 2
Efficacy of Intraoperative Fluorescence Diagnosis in Meningioma surgeryMeningiomameningiomaJPRN-jRCTs031210158Masahide Matsuda22
Not yet recruiting
Not Applicable
Saving joint and minimizing recurrence rate of grade 3 GCTCTRI/2022/10/046435Department of orthopedics
Recruiting
Phase 2
A prospective interventional study to evaluate the validity of sentinel node biopsy for omitting axillary dissection after neoadjuvant chemotherapy for breast cancer patients with axillary lymph node metastasisBreast cancerJPRN-UMIN000048307Cancer Institute Hospital of JFCR Breast Surgical Oncology, Breast Oncology center80
Recruiting
Unknown
Evaluation of efficacy and safety of postoperative proton beam therapy for resectable pancreatic cancerBorderline resectable or unresectable locally advanced pancreatic cancerJPRN-UMIN000051399Hyogo Ion Beam Medical Center40